Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 3, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • DRY SWAB-DIRECT RT-PCR TO RAMP UP TEST FREQUENCY

ICRISAT Biological Science Research Technician Vacancy Available

Govt Chittaranjan National Cancer Institute Research Associate Recruitment

DRY SWAB-DIRECT RT-PCR TO RAMP UP TEST FREQUENCY
  • BiotechToday
  • World

DRY SWAB-DIRECT RT-PCR TO RAMP UP TEST FREQUENCY

bioxone December 3, 2020December 3, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA

The Indian Council of Medical Research (ICMR) agreed a dry swab-direct RT-PCR testing method for the COVID-19 virus which is presently developed by CSIR-Centre for Cellular and Molecular Biology (CCMB).

This new method of dry swab-direct test aimed at ascending the test by atleast two to three folds with no new investment of resources. Coronavirus testing was conducted by CSIR-CCMB since April 2020. After working with the workers of Telangana, the researchers recognised that the testing process is quite slow. To come up with verified results at a faster rate, they issued this dry swab RNA-extraction free testing method for the Novel Coronavirus. 

This new method of testing readily involves collecting and transporting the nasal swab in its dry state thus making it easier for transportation and handling. In this method the step of RNA isolation is deleted from the sample. The dry swab RT-PCR method is basically cost effective and easy to apply with null demand of new kits and the existing, manpower can execute this with no extra training. It also holds a meritorious position for every possible setting and has the potential of bringing down the cost and time of testing by 40-50%.

Thus, the Dry Swab Direct RT-PCR method has been issued in peer reviewed journal by CSIR-CCMB and also by the other scientific groups and in other journals across the world.

Also read: ENGINEERED ONCOLYTIC ADENOVIRUS TO TREAT METASTATIC CANCER

Site: https://www.livemint.com/science/health/to-ramp-up-covid-19-testing-icmr-approves-dry-swab-direct-rt-pcr-method-how-it-works-11606560777763.html

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged 40-50% BiotechToday cost effective COVID-19 CSIR-CCMB dry state dry-swab testing extraction ICMR india journals RNA RT-PCR SARS-CoV-2 Telangana

One thought on “DRY SWAB-DIRECT RT-PCR TO RAMP UP TEST FREQUENCY”

  1. Pingback: TRPC1 – a protein that makes muscles stronger without exercise discovered - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Govt Chittaranjan National Cancer Institute Research Associate Recruitment

bioxone December 3, 2020

-Shristi Sharma, Team bioXone Chittaranjan National Cancer Institute Research Associate Recruitment. Chittaranjan National Cancer Institute Jobs. MSc Life Science Jobs. Research Associate Vacancy. Interested and eligible candidates can check out all of the details on the same below:  CHITTARANJAN NATIONAL CANCER INSTITUTE 37, S. P. Mukherjee Road, Kolkata – 700 026 Advertisement No: 612/2020 Name […]

Related Post

  • BiotechToday
  • World

ARHGAP42 gene deficiency linked with chILD

bioxone July 10, 2021July 9, 2021

Madhavi Bhatia, NIPER Guwahati Childhood interstitial lung disease (chILD) is a heterogeneous group of rare disorders which is characterized by diffuse pulmonary infiltrates, respiratory signs and symptoms, and impaired gas exchange. These disorders are very difficult to diagnose and are associated with substantial morbidity and mortality. chILD, systemic hypertension, and immune abnormalities are seen in […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

ELECTRIC ORGAN IN CATFISH | A FOUNDATION TO EVOLUTIONARY DIVERSIFICATION

bioxone September 23, 2020September 23, 2020

-Shrestha Dutta, Amity University Kolkata South American Gymnotiform knifefish have electric organs that create electric fields for electro-location and electro-communication. Electric organs can be obtained from the myogenic or the neurogenic cells. The early-stage development of EOs is still obscure. We describe the advancement of the mEO in the Gymnotiform bluntnose knifefish, Brachyhypopomus gaudio. EO […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Spliceosome-targeted Therapies in Triple-Negative Breast Cancer treatment

bioxone January 27, 2021January 27, 2021

Sayak Banerjee, Amity University Kolkata According to the scientists at Baylor College of Medicine, antiviral immune pathways in triple-negative breast cancers (TNBC) can be activated by therapeutics targeting RNA splicing along with the stimulation of tumour cell death. Around 10-20% of breast cancers are triple-negative, which signifies that they are negative not only for estrogen […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy